Literature DB >> 24756933

Cost-effectiveness of early laparoscopic cholecystectomy for mild acute gallstone pancreatitis.

S Morris1, K S Gurusamy, N Patel, B R Davidson.   

Abstract

BACKGROUND: A recent Cochrane review suggested that laparoscopic cholecystectomy carried out early following mild gallstone pancreatitis was safe. This study compared the cost-effectiveness of laparoscopic cholecystectomy performed within 3 days of admission, during the same admission but after more than 3 days, or electively in a subsequent admission.
METHODS: A model-based cost-utility analysis was performed estimating mean costs and quality-adjusted life-years (QALYs) per patient in the UK National Health Service with a 1-year time horizon. A decision tree model was constructed and populated with probabilities, outcomes and cost data from published sources for mild gallstone pancreatitis, including one-way and probabilistic sensitivity analyses.
RESULTS: The costs of laparoscopic cholecystectomy performed within 3 days of admission, beyond 3 days but in the same admission, and electively in a subsequent admission were € 2748, € 3543 and € 3752 respectively; the QALYs were 0.888, 0.888 and 0.884 respectively. Early laparoscopic cholecystectomy had a 91 per cent probability of being cost-effective at the maximum willingness to pay for a QALY commonly used in the UK. It is acknowledged that many hospitals do not have access to magnetic resonance cholangiopancreatography and endoscopic retrograde cholangiopancreatography, especially at weekends, and that implementing a 3-day target is unrealistic without allocating new resources that could erode the cost-effectiveness.
CONCLUSION: Performing laparoscopic cholecystectomy for mild gallstone pancreatitis within 3 days of admission is cost-effective, but may not be feasible without significant resource allocation. After 3 days there is little financial advantage to same-admission operation.
© 2014 BJS Society Ltd. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 24756933     DOI: 10.1002/bjs.9501

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  10 in total

Review 1.  Delayed laparoscopic cholecystectomy increases the total hospital stay compared to an early laparoscopic cholecystectomy after acute cholecystitis: an updated meta-analysis of randomized controlled trials.

Authors:  Benjamin Menahem; Andrea Mulliri; Audrey Fohlen; Lydia Guittet; Arnaud Alves; Jean Lubrano
Journal:  HPB (Oxford)       Date:  2015-07-27       Impact factor: 3.647

2.  Laparoscopic cholecystectomy in acute mild gallstone pancreatitis: how early is safe?

Authors:  Pablo Giuffrida; David Biagiola; Agustín Cristiano; Victoria Ardiles; Martín de Santibañes; Rodrigo Sanchez Clariá; Juan Pekolj; Eduardo de Santibañes; Oscar Mazza
Journal:  Updates Surg       Date:  2020-02-03

3.  Inpatient magnetic resonance cholangiopancreatography: does it increase the efficiency in emergency hepatopancreaticobiliary surgery services?

Authors:  J A Milburn; J A Bailey; Wk Dunn; I C Cameron; D S Gomez
Journal:  Ann R Coll Surg Engl       Date:  2016-09-23       Impact factor: 1.891

4.  Higher cost of single incision laparoscopic cholecystectomy due to longer operating time. A study of opportunity cost based on meta-analysis.

Authors:  F Fuertes-Guirò; M Girabent-Farrés
Journal:  G Chir       Date:  2018 Jan-Feb

5.  Acute care surgery: a means for providing cost-effective, quality care for gallstone pancreatitis.

Authors:  Patrick B Murphy; Dave Paskar; Richard Hilsden; Jennifer Koichopolos; Tina S Mele
Journal:  World J Emerg Surg       Date:  2017-04-28       Impact factor: 5.469

6.  Early vs late cholecystectomy in mild gall stone pancreatitis: An updated meta-analysis and review of literature.

Authors:  Saqib Walayat; Muhammad Baig; Srinivas R Puli
Journal:  World J Clin Cases       Date:  2021-05-06       Impact factor: 1.337

7.  Cost-effectiveness of nivolumab plus ipilimumab as first-line treatment for American patients with unresectable malignant pleural mesothelioma.

Authors:  Zhuo-Miao Ye; Zi-Qing Tang; Zhe Xu; Qin Zhou; Huan Li
Journal:  Front Public Health       Date:  2022-07-22

8.  The Association Between Helicobacter Pylori Infection and Liver and Biliary Tract Disorders.

Authors:  D Popescu; D Andronescu; P A Babes
Journal:  Curr Health Sci J       Date:  2018-03-27

9.  Incremental net benefit of cholecystectomy compared with alternative treatments in people with gallstones or cholecystitis: a systematic review and meta-analysis of cost-utility studies.

Authors:  Bhavani Shankara Bagepally; S Sajith Kumar; Meenakumari Natarajan; Akhil Sasidharan
Journal:  BMJ Open Gastroenterol       Date:  2022-01

Review 10.  The Need for Standardizing Diagnosis, Treatment and Clinical Care of Cholecystitis and Biliary Colic in Gallbladder Disease.

Authors:  Gerard Doherty; Matthew Manktelow; Brendan Skelly; Paddy Gillespie; Anthony J Bjourson; Steven Watterson
Journal:  Medicina (Kaunas)       Date:  2022-03-05       Impact factor: 2.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.